Steve E. Krognes's most recent trade in Guardant Health Inc was a trade of 6,833 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardant Health Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 6,833 | 6,833 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 4,203 | 4,203 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 6,674 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 6,674 | 17,665 (0%) | 0% | 0 | Common Stock | |
| Pliant Therapeutics Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 30,000 | - | - | Common Stock (Right to Buy) | |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 6,037 | 31,794 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 154 | 10,991 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 154 | 2,006 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 155 | 10,837 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 155 | 2,160 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 154 | 2,315 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 154 | 10,682 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 154 | 2,469 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 154 | 10,528 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 154 | 10,374 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 154 | 2,623 | - | - | Restricted Stock Units | |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 20.81 per share. | 07 Jan 2025 | 3,339 | 25,757 (0%) | 0% | 20.8 | 69,485 | Common Stock |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 20.25 per share. | 31 Dec 2024 | 30,000 | 29,096 (0%) | 0% | 20.3 | 607,500 | Common Stock |
| Guardant Health Inc | Krognes E. Steven | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 155 | 10,220 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 155 | 2,777 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2024 | 154 | 2,932 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2024 | 154 | 10,065 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2024 | 154 | 3,086 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2024 | 154 | 9,911 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 29.03 per share. | 30 Sep 2024 | 30,000 | 29,096 (0%) | 0% | 29.0 | 870,900 | Common Stock |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 154 | 3,240 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 154 | 9,757 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2024 | 155 | 3,394 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2024 | 155 | 9,603 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 23.79 per share. | 20 Aug 2024 | 1,727 | 32,677 (0%) | 0% | 23.8 | 41,085 | Common Stock |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 154 | 9,448 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 154 | 3,549 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 154 | 3,703 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 154 | 9,294 (0%) | 0% | 0 | Common Stock | |
| Pliant Therapeutics Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 53,528 | 53,528 | - | - | Common Stock (Right to Buy) | |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 22.12 per share. | 13 Jun 2024 | 29,900 | 34,504 (0%) | 0% | 22.1 | 661,388 | Common Stock |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 21.79 per share. | 13 Jun 2024 | 688 | 52,620 (0%) | 0% | 21.8 | 14,992 | Common Stock |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 22.80 per share. | 13 Jun 2024 | 100 | 34,404 (0%) | 0% | 22.8 | 2,280 | Common Stock |
| Guardant Health Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 10,703 | 10,703 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 6,674 | 6,674 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 5,592 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 5,592 | 9,140 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,901 | 17,901 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,967 | 53,308 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 155 | 3,857 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 155 | 3,548 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 154 | 4,012 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steven E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 154 | 3,393 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Steve E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 20.50 per share. | 01 Apr 2024 | 92,500 | 47,341 (0%) | 0% | 20.5 | 1,896,250 | Common Stock |
| Guardant Health Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 154 | 3,239 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 154 | 4,166 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 154 | 4,320 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 154 | 3,085 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Krognes E. Steve | Director | Sale of securities on an exchange or to another person at price $ 17.29 per share. | 13 Feb 2024 | 2,750 | 139,841 (0%) | 0% | 17.3 | 47,548 | Common Stock |
| Guardant Health Inc | Krognes E. Steve | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 155 | 4,474 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Krognes Steve E. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 155 | 2,931 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Krognes E. Steve | Director | Sale of securities on an exchange or to another person at price $ 19.43 per share. | 05 Jan 2024 | 3,208 | 142,591 (0%) | 0% | 19.4 | 62,331 | Common Stock |
| Guardant Health Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 154 | 2,776 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Krognes Steve E. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 154 | 4,629 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Krognes Steve E. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 154 | 2,622 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | E. Krognes Steve | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 154 | 4,783 | - | - | RESTRICTED STOCK UNITS | |
| Denali Therapeutics Inc | Steve E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 22.60 per share. | 21 Aug 2023 | 1,419 | 145,799 (0%) | 0% | 22.6 | 32,069 | Common Stock |
| Guardant Health Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 154 | 5,400 | - | - | RESTRICTED STOCK UNITS | |
| Guardant Health Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 154 | 2,005 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 1,851 | 1,851 (0%) | 0% | 0 | COMMON STOCK | |
| Guardant Health Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 1,851 | 5,554 | - | - | RESTRICTED STOCK UNITS | |
| Gritstone Bio Inc | Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 8,803 | 8,803 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 5,592 | 5,592 | - | - | RESTRICTED STOCK UNITS | |
| Denali Therapeutics Inc | Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,649 | 12,649 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,216 | 147,218 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Steve E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 30.10 per share. | 13 Feb 2023 | 2,119 | 143,002 (0%) | 0% | 30.1 | 63,782 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 30.88 per share. | 08 Feb 2023 | 1,377 | 145,121 (0%) | 0% | 30.9 | 42,522 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 28.44 per share. | 05 Jan 2023 | 2,970 | 146,498 (0%) | 0% | 28.4 | 84,467 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | Director | Sale of securities on an exchange or to another person at price $ 33.22 per share. | 19 Aug 2022 | 2,253 | 149,468 (0%) | 0% | 33.2 | 74,845 | Common Stock |
| Guardant Health Inc | Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 11,879 | 11,879 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 7,405 | 7,405 | - | - | RESTRICTED STOCK UNITS | |
| Denali Therapeutics Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. | 19 Jul 2022 | 62,500 | 151,721 (0%) | 0% | 0.7 | 42,500 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2022 | 62,500 | 0 | - | - | Stock Option (right to buy) | |
| Gritstone Bio Inc | Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 34.69 per share. | 11 Feb 2022 | 2,560 | 120,221 (0%) | 0% | 34.7 | 88,806 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 37.09 per share. | 09 Feb 2022 | 1,296 | 122,781 (0%) | 0% | 37.1 | 48,073 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 44.75 per share. | 05 Jan 2022 | 2,225 | 124,077 (0%) | 0% | 44.8 | 99,569 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 93,000 | 93,000 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 31,000 | 126,302 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 49.52 per share. | 19 Aug 2021 | 2,085 | 95,502 (0%) | 0% | 49.5 | 103,249 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 50.07 per share. | 19 Aug 2021 | 200 | 95,302 (0%) | 0% | 50.1 | 10,014 | Common Stock |
| Gritstone Bio Inc | Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 62.04 per share. | 15 Mar 2021 | 32,326 | 854,416 (0%) | 0% | 62.0 | 2,005,602 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 61.16 per share. | 15 Mar 2021 | 13,258 | 886,742 (0%) | 0% | 61.2 | 810,912 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 62.71 per share. | 15 Mar 2021 | 3,258 | 851,158 (0%) | 0% | 62.7 | 204,319 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 63.67 per share. | 15 Mar 2021 | 1,158 | 850,000 (0%) | 0% | 63.7 | 73,730 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 64.27 per share. | 16 Feb 2021 | 22,684 | 927,316 (0%) | 0% | 64.3 | 1,457,923 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 66.20 per share. | 16 Feb 2021 | 16,616 | 900,501 (0%) | 0% | 66.2 | 1,099,996 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 65.04 per share. | 16 Feb 2021 | 10,199 | 917,117 (0%) | 0% | 65.0 | 663,323 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 66.80 per share. | 16 Feb 2021 | 501 | 900,000 (0%) | 0% | 66.8 | 33,468 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 70.17 per share. | 11 Feb 2021 | 2,635 | 97,987 (0%) | 0% | 70.2 | 184,908 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 71.43 per share. | 11 Feb 2021 | 400 | 97,587 (0%) | 0% | 71.4 | 28,571 | Common Stock |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2021 | 4,250 | 8,500 | - | - | Restricted Stock Units | |
| Denali Therapeutics Inc | Steve E. Krognes | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2021 | 4,250 | 14,427 (0%) | 0% | 0 | Common Stock |